The Enterprise Value as of December 2025 (TTM) for Recce Pharmaceuticals Ltd (RCE.AX) is 168.05M

According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 168.05M. This represents a change of 69.70% compared to the average of 99.02M of the last 4 quarters.

Recce Pharmaceuticals Ltd (RCE.AX) Historical Enterprise Value (quarterly & annually)

How has RCE.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Recce Pharmaceuticals Ltd over the last ten years is 69.03M. The current 168.05M Enterprise Value has changed 24.24% with respect to the historical average. Over the past ten years (40 quarters), RCE.AX's Enterprise Value was at its highest in in the June 2022 quarter at 146.60M. The Enterprise Value was at its lowest in in the December 2012 quarter at 0.

Recce Pharmaceuticals Ltd (RCE.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Recce Pharmaceuticals Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Recce Pharmaceuticals Ltd (RCE.AX) Average Enterprise Value

How has RCE.AX Enterprise Value performed in the past?

The current Enterprise Value of Recce Pharmaceuticals Ltd (RCE.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Recce Pharmaceuticals Ltd (RCE.AX) Enterprise Value vs. Peers

How is RCE.AX’s Enterprise Value compared to its peers?

Recce Pharmaceuticals Ltd’s Enterprise Value is greater than Actinogen Medical Limited (164.97M), greater than Arovella Therapeutics Limited (76.42M), greater than Alterity Therapeutics Limited (58.48M), greater than Imugene Limited (81.08M), greater than Island Pharmaceuticals Limited (106.53M), greater than EZZ Life Science Holdings Limited (49.98M), greater than Biome Australia Limited (86.93M), greater than SDI Limited (121.32M), greater than Paradigm Biopharmaceuticals Limited (109.32M), greater than PainChek Limited (67.29M),

Build a custom stock screener for Recce Pharmaceuticals Ltd (RCE.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recce Pharmaceuticals Ltd (RCE.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.